Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 5/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | FBP1 | P09467 | 2/20 | 0.47 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | HTR7 | P34969 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7144737 | 0.96 | NLRP3 (0.66) | NLRP3ALDH1A1LMNAFBP1GSTO1 | |
| SCHEMBL7617355 | 0.95 | NLRP3 (0.63) | NLRP3ALDH1A1LMNAFBP1GSTO1 | |
| SCHEMBL7613905 | 0.91 | NLRP3 (0.61) | NLRP3ALDH1A1LMNAFBP1GSTO1 | |
| SCHEMBL7137330 | 0.85 | NLRP3 (0.76) | NLRP3FBP1 | |
| SCHEMBL6555763 | 0.85 | NLRP3 (0.76) | NLRP3FBP1 | |
| SCHEMBL7142667 | 0.84 | NLRP3 (0.74) | NLRP3FBP1 | |
| SCHEMBL7139143 | 0.83 | NLRP3 (0.75) | NLRP3LMNAFBP1GSTO1KMT2A | |
| SCHEMBL7143625 | 0.83 | NLRP3 (0.71) | NLRP3ALDH1A1LMNAFBP1KMT2A | |
| SCHEMBL27437801 | 0.82 | NLRP3 (0.64) | NLRP3FBP1GSTO1KMT2A | |
| SCHEMBL6513806 | 0.81 | NLRP3 (1.00) | NLRP3FBP1GSTO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0964849-B1 | SULFONYL UREA DERIVATIVES AND THEIR USE IN THE CONTROL OF INTERLEUKIN-1 ACTIVITY | PFIZER (US) | 2003-06-04 | — | — | EP | disclosed |
| EP-1270565-A1 | 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives | PFIZER INC. (US) | 2003-01-02 | — | — | EP | disclosed |
| EP-1270554-A1 | Sulfonyl urea derivatives and their use in the control of interleukin-1 activity | PFIZER INC. (US) | 2003-01-02 | — | — | EP | disclosed |
| US-6433009-B1 | TREATMENT OF AUTOIMMUNE, CARDIOVASCULAR, NERVOUS SYSTEM, GASTROINTESTINAL, RESPIRATORY SYSTEM, AND VIRAL DISORDERS; ANTIDIABETIC, ANTIARTHRITIC, ANTIINFLAMMATORY AND ANTIDEPRESSANT AGENTS | PFIZER INC | 2002-08-13 | — | — | US | disclosed |
| US-6166064-A | Sulfonyl urea derivatives and their use in the control of interleukin-1 activity | PFIZER INC (US) | 2000-12-26 | — | — | US | disclosed |